NLTX

Neoleukin Therapeutics, Inc. NLTX

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NLTX LCI DMKPQ BIOR OSA TSBX TVRD CSCI OMGA CHRO
6M -81.14 % -71.20 % 0.00 % 0.00 % 0.00 % -1.31 % -85.90 % -36.64 % -88.68 % -94.23 %
YTD 0.00 % -67.79 % 0.71 % 0.00 % 0.00 % -33.95 % -17.96 % -22.71 % -81.77 % -81.33 %
1Y -69.39 % -67.48 % 907.14 % -53.21 % 0.00 % -46.69 % -17.96 % -20.97 % -95.79 % -87.38 %
3Y -98.71 % -97.62 % -99.99 % -99.40 % -95.27 % -96.77 % -17.96 % -64.83 % -97.81 % -97.19 %
5Y -92.61 % -98.99 % -100.00 % -99.99 % -95.12 % -96.77 % -17.96 % -64.83 % -99.11 % -97.19 %
10Y -98.54 % -99.39 % -100.00 % -99.99 % -95.12 % -96.77 % -17.96 % -64.83 % -99.11 % -97.19 %
From the beginning -98.54 % -93.57 % -100.00 % -99.99 % -95.12 % -96.77 % -17.96 % -64.83 % -99.11 % -97.19 %

Dividend